Issue 2/2019
Content (12 Articles)
Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review
Jeongshim Lee, Won Sup Yoon, Woong Sub Koom, Chai Hong Rim
Comparison of relative and absolute rectal dose–volume parameters and clinical correlation with acute and late radiation proctitis in prostate cancer patients
Roman Paleny, Michael Bremer, Daniel Walacides, Silke Mainwaring, Kristina Weber, Christoph Henkenberens
Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer
Filippo Alongi, Rosario Mazzola, Alba Fiorentino, Stefanie Corradini, Dario Aiello, Vanessa Figlia, Fabiana Gregucci, Riccardo Ballario, Stefano Cavalleri, Ruggero Ruggieri
Towards a universal MRI atlas of the prostate and prostate zones
Kyle R. Padgett, Amy Swallen, Sara Pirozzi, Jon Piper, Felix M. Chinea, Matthew C. Abramowitz, Aaron Nelson, Alan Pollack, Radka Stoyanova
Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy
Marco M. E. Vogel, Kerstin A. Kessel, Jürgen E. Gschwend, Wilko Weichert, Jan J. Wilkens, Stephanie E. Combs
MRI-guided localization of the dominant intraprostatic lesion and dose analysis of volumetric modulated arc therapy planning for prostate cancer
Jörg Tamihardja, Maria Zenk, Michael Flentje
Penile bulb sparing in prostate cancer radiotherapy
F. Böckelmann, M. Hammon, S. Lettmaier, R. Fietkau, C. Bert, F. Putz
Treatment outcomes of radiotherapy for primary spinal cord glioma
Seo Hee Choi, Hong In Yoon, Seong Yi, Jong Won Park, JaeHo Cho, Dong Ah Shin, Yoon Ha, Dong-Seok Kim, Se Hoon Kim, Seung-Koo Lee, Jong Hee Chang, Chang-Ok Suh
A density assignment method for dose monitoring in head-and-neck radiotherapy
A. Barateau, N. Perichon, J. Castelli, U. Schick, O. Henry, E. Chajon, A. Simon, C. Lafond, R. De Crevoisier
Genetische Risikofaktoren für ein Zweitmalignom bei Kindern nach einer ersten onkologischen Erkrankung
Martin G. Sauer
Stereotaktische Strahlentherapie übertrifft Sorafenib beim fortgeschrittenen hepatozellulären Karzinom im Hinblick auf das Überleben
Ping Jiang, Jürgen Dunst
Risiko von Zweitmalignomen nach platinbasierter Chemotherapie von Hodentumoren
David Utz, Arndt-Christian Müller